Scilex Holding (SCLX) Change in Inventory (2022 - 2026)
Scilex Holding (SCLX) posted quarterly Change in Inventory of -$257000.0 for Q1 2026, down 144.01% year-over-year from $584000.0 in Q1 2025, and up 49.51% quarter-over-quarter from -$509000.0 in Q4 2025.
Scilex Holding (SCLX) Change in Inventory (2022 - 2026) Analysis & Trends
Scilex Holding's Change in Inventory history runs 5 years deep, the most recent figure standing at -$257000.0 for Q1 2026.
- In Q1 2026, Change in Inventory fell 144.01% year-over-year to -$257000.0; the TTM figure through Mar 2026 stood at -$2.6 million (down 1636.84% YoY), while the FY2025 annual figure was -$1.8 million, down 23.05% from the prior year.
- Change in Inventory for Q1 2026 stood at -$257000.0, up from -$509000.0 in the prior quarter.
- The five-year high for Change in Inventory was $897000.0 in Q1 2023, with the low at -$1.4 million in Q3 2025.
- The 5-year median for Change in Inventory is -$257000.0 (2026), against an average of -$109647.1.
- The sharpest annual moves came in 2023 and 2025: Change in Inventory surged 466.96% in 2023, then tumbled 1597.06% in 2025.
- Scilex Holding's Change in Inventory stood at $445000.0 in 2022, then tumbled by 38.65% to $273000.0 in 2023, then sank by 87.55% to $34000.0 in 2024, then sank by 1597.06% to -$509000.0 in 2025, then surged by 49.51% to -$257000.0 in 2026.
- Business Quant data shows SCLX's Change in Inventory at -$257000.0 in Q1 2026, -$509000.0 in Q4 2025, and -$1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.37 Bn | 632.61 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 469.99 Bn | 463.42 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.26 Bn | 295.57 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.45 Bn | 252.55 Bn | 12.86 Bn | - |
| 6 | Amgen | 236.73 Bn | 222.74 Bn | 7.24 Bn | 31.00 Mn |
| 7 | Gilead Sciences | 182.06 Bn | 178.88 Bn | 6.22 Bn | 145.00 Mn |
| 8 | Pfizer | 159.32 Bn | 147.62 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.03 Bn | 101.87 Bn | 8.24 Bn | - |
| 10 | Scilex Holding | 39.28 Mn | -73.51 Mn | 3.97 Mn | -360,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -257,000.00 |
| Mar 31, 2026 | -257,000.00 |
| Dec 31, 2025 | -509,000.00 |
| Dec 31, 2025 | -509,000.00 |
| Sep 30, 2025 | -1.38 Mn |
| Sep 30, 2025 | -1.38 Mn |
| Jun 30, 2025 | -496,000.00 |
| Jun 30, 2025 | -496,000.00 |
| Mar 31, 2025 | 584,000.00 |
| Mar 31, 2025 | 584,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2024 | -358,000.00 |
| Sep 30, 2024 | -358,000.00 |
| Jun 30, 2024 | -412,000.00 |
| Jun 30, 2024 | -412,000.00 |
| Mar 31, 2024 | -726,000.00 |
| Mar 31, 2024 | -726,000.00 |
| Dec 31, 2023 | 273,000.00 |
| Dec 31, 2023 | 273,000.00 |